Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality

Allan Linneberg; Rikke Kart Jacobsen; Lasse Jespersen; Steen Z Abildstrøm

doi:10.1016/j.jaci.2011.09.007

Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality

Allan Linneberg, Rikke Kart Jacobsen, Lasse Jespersen, Steen Z Abildstrøm

Department of Cardiology

69 Citations (Scopus)

Abstract

Subcutaneous allergen-specific immunotherapy (SCIT) is a well-documented treatment of IgE-mediated allergic disease. Little is known about potential effects of SCIT on the risk of other chronic immune-related diseases. Over the years, a few casuistic reports have caused concern that SCIT might act as a trigger of autoimmune disease.

Original language	English
Journal	Journal of Allergy and Clinical Immunology
Volume	129
Issue number	2
Pages (from-to)	413-9
Number of pages	7
ISSN	0091-6749
DOIs	https://doi.org/10.1016/j.jaci.2011.09.007
Publication status	Published - 2012

Access to Document

10.1016/j.jaci.2011.09.007

Cite this

Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. / Linneberg, Allan ; Jacobsen, Rikke Kart; Jespersen, Lasse et al.
In: Journal of Allergy and Clinical Immunology, Vol. 129, No. 2, 2012, p. 413-9.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{ff743f4624334c9e9245929bd8857579,

title = "Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality",

abstract = "Subcutaneous allergen-specific immunotherapy (SCIT) is a well-documented treatment of IgE-mediated allergic disease. Little is known about potential effects of SCIT on the risk of other chronic immune-related diseases. Over the years, a few casuistic reports have caused concern that SCIT might act as a trigger of autoimmune disease.",

author = "Allan Linneberg and Jacobsen, {Rikke Kart} and Lasse Jespersen and Abildstr{\o}m, {Steen Z}",

year = "2012",

doi = "10.1016/j.jaci.2011.09.007",

language = "English",

volume = "129",

pages = "413--9",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality

AU - Linneberg, Allan

AU - Jacobsen, Rikke Kart

AU - Jespersen, Lasse

AU - Abildstrøm, Steen Z

PY - 2012

Y1 - 2012

N2 - Subcutaneous allergen-specific immunotherapy (SCIT) is a well-documented treatment of IgE-mediated allergic disease. Little is known about potential effects of SCIT on the risk of other chronic immune-related diseases. Over the years, a few casuistic reports have caused concern that SCIT might act as a trigger of autoimmune disease.

AB - Subcutaneous allergen-specific immunotherapy (SCIT) is a well-documented treatment of IgE-mediated allergic disease. Little is known about potential effects of SCIT on the risk of other chronic immune-related diseases. Over the years, a few casuistic reports have caused concern that SCIT might act as a trigger of autoimmune disease.

U2 - 10.1016/j.jaci.2011.09.007

DO - 10.1016/j.jaci.2011.09.007

M3 - Journal article

C2 - 22004944

SN - 0091-6749

VL - 129

SP - 413

EP - 419

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 2

ER -

Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality

Abstract

Access to Document

Fingerprint

Cite this